SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL- salicylic acid spray 
J. Strickland and Co.

----------

Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Spray

Drug Facts

Active Ingredient

Salicylic Acid, 2%

Purpose

Antidandruff

Use:

Controls scalp itching and flaking due to dandruff

Warnings

For external use only

When using this product

avoid contact with eyes. If contact, rinse eyes thoroughly with water.

Stop use and consult a doctor if

condition worsens or does not improve after regular use of this product as directed.

Keep out of reach of children.

If swallowed, get medical help or call a Poison Control Center at once.

Directions

Spray to apply to the affected area 1-4 times daily, or as directed by a doctor

Inactive Ingredients

Water, Glycerin, Sodium Hydroxide, PEG-40 Hydrogenate Castor Oil, PEG-12 Dimethicone, Propylene Glycol, Hydrolyzed Collagen, Diazolidinyl Urea, Disodium EDT, Methylparaben, Propylparaben, Ethylhexylglycerin, PEG-12 Alyl Ether, PEG-12, Butylene Glycol, Phenoxyethanol, Fragrance

Package Labeling:

image description

SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL 
salicylic acid spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:12022-032
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
PEG-12 DIMETHICONE (300 CST) (UNII: ZEL54N6W95)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
POLYETHYLENE GLYCOL 600 (UNII: NL4J9F21N9)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:12022-032-00355 mL in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM03201/01/2020
Labeler - J. Strickland and Co. (007023112)

Revised: 10/2023
Document Id: 0834eb14-2e95-ef47-e063-6294a90ad922
Set id: 961ffab9-4e1b-83f3-e053-2a95a90af5fe
Version: 3
Effective Time: 20231021
 
J. Strickland and Co.